Speaking at Pharmaconex: Dr. Jordi Amagat on Far-UVC for Continuous Cleanroom Decontamination

Continuous Cleanroom Decontamination: Implementation of Far-UVC

Pharmaconex Cleanroom Technology Conference – September 2, 2025

On September 2, Dr. Jordi Amagat Molas, Senior Manager Life Science & Pharma at UV Medico, will take the stage at the Cleanroom Technology Conference at Pharmaconex 2025 in Cairo. His talk, “Continuous Cleanroom Decontamination: Implementation of Far-UVC”, will explore how next-generation decontamination technology is transforming pharmaceutical cleanroom operations.

Why this matters

Pharmaceutical manufacturing is under increasing pressure to comply with Annex 1 of the EU GMP guidelines, which emphasizes stricter microbial control and continuous contamination prevention strategies. Traditional cleaning and disinfection methods are no longer sufficient on their own — especially when it comes to airborne pathogens and high-traffic areas.

Far-UVC: A breakthrough for cleanrooms

Far-UVC (222 nm) light provides an effective, continuous, and safe method for reducing bioburden in cleanrooms — even during active operations. Unlike conventional UV-C, Far-UVC cannot penetrate beyond the outer layers of skin or eyes, making it safe for occupied environments.

Dr. Amagat will share:

• Scientific evidence showing Far-UVC’s proven ability to inactivate bacteria, viruses, and mold while remaining safe for personnel.

• Case studies from hospitals, ICUs, and pharmaceutical cleanrooms — including documented outcomes such as the elimination of HAIs at Airforces Hospital Egypt following UV222 deployment.

• Implementation strategies for integrating Far-UVC into cleanroom entry points, personnel/material transfer zones, aseptic filling lines, and core production areas.

• Validation results from global pharma companies demonstrating continuous reduction of microbial contamination in compliance with Annex 1.

Driving sustainability and efficiency

As part of Track 2: Cleanroom Operations & Sustainability, Jordi will also address how Far-UVC supports cleaner, safer, and more energy-efficient operations by reducing reliance on chemical disinfectants and mitigating batch rejections caused by contamination.

📍 Session details

• Speaker: Dr. Jordi Amagat Molas, UV Medico

• Topic: Continuous Cleanroom Decontamination: Implementation of Far-UVC

• Date & Time: Tuesday, September 2, 2025 – 14:15–15:00 (Cairo time)

• Track 2: Cleanroom Operations & Sustainability

Far-UVC is not just a new tool — it is shaping the future of continuous contamination control in pharma. Don’t miss this session if you are working in cleanroom design, quality assurance, microbiological control, or operations management.